Clinical features and prognostic factors affecting survival of ambulatory followed COVID-19 patients aged over 65 years

Basit Öğe Kaydı
dc.contributor.authorYalcinsoy, Murat
dc.contributor.authorSelcuk, Engin Burak
dc.contributor.authorUckac, Kadir
dc.contributor.authorSahin, Abdullah Fahri
dc.contributor.authorTas, Ayse
dc.contributor.authorKasapoglu, Umut
dc.contributor.authorBentli, Recep
dc.date.accessioned2025-10-24T18:10:00Z
dc.date.available2025-10-24T18:10:00Z
dc.date.issued2022
dc.departmentMalatya Turgut Özal Üniversitesi
dc.description.abstractAim: The majority of the patients with COVID-19 are followed ambulatory. Determination of prognostic factors of mortality in risky groups is essential to improve patient management. The aim of this study is to describe the clinical presentation in patients over 65 years of age with COVID-19 who are followed up at home by a physician and provide insights into the initial prognostic factors in this distinctive population. Material and Methods: This is a retrospective and observational study. Clinical records of the patients aged over 65 years who were visited by the filiation team, including a physician at home, due to the diagnosis of COVID-19 disease within 2 months were reviewed. Factors affecting mortality were examined. Results: Our study included 51 deceased (mean age: 75,1 +/- 9,0 years, 40,2% males), and 102 patients with COVID-19 who survived (mean age: 73,0 +/- 6,9 years, 68,6% male). Platelet count ( < 150.000, OR 7,26, p=0,001), CRP level ( < 4, OR 4,55, p=0,02), albumin level ( OR 3,24, p=0,02), and Troponin I level (OR 0,03, p=0,02) were the strongest predictors for death. When propensity score matching was applied, gender (male, OR 7,14, p=0,02) and platelet count (< 150.000, OR 5,34, p=0,02) were the strongest predictor Discussion: Elderly COVID-19 patients have a high mortality rate. An easily measurable and accessible platelet count may be a predictor of a bad outcome. Close follow-up and timely treatment may significantly reduce mortality in high- risk elderly patients under.
dc.identifier.doi10.4328/ACAM.21083
dc.identifier.endpage668
dc.identifier.issn2667-663X
dc.identifier.issue6
dc.identifier.startpage663
dc.identifier.urihttps://doi.org/10.4328/ACAM.21083
dc.identifier.urihttps://hdl.handle.net/20.500.12899/3934
dc.identifier.volume13
dc.identifier.wosWOS:001027513600016
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherBayrakol Medical Publisher
dc.relation.ispartofAnnals Of Clinical And Analytical Medicine
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_20251023
dc.subjectCOVID-19; Frail Elderly; Ambulatory Care; Mortality
dc.titleClinical features and prognostic factors affecting survival of ambulatory followed COVID-19 patients aged over 65 years
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu